The Actim Partus test to predict pre-term birth in asymptomatic high-risk women

Journal of Obstetrics and Gynaecology

Volumn 32, Issue 2, 2012, Pages 132-134

  Khambay, H ^a   Bolt, L A ^a   Chandiramani, M ^a,b   De Greeff, A ^a   Filmer, J E ^a   Shennan, A H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Actim partus test; FFN test; PIGFBP 1; Pre term birth

Indexed keywords

FIBRONECTIN;

ACTIM PARTUS TEST; ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; DELIVERY; FEMALE; GESTATION PERIOD; HIGH RISK POPULATION; HUMAN; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ADULT; BIOLOGICAL MARKERS; FEMALE; FIBRONECTINS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREMATURE BIRTH; RISK FACTORS; SENSITIVITY AND SPECIFICITY; VAGINAL SMEARS;

EID: 84856651264     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.3109/01443615.2011.637649     Document Type: Article

References (8)

1. Bittar RE, da Fonseca EB, de Carvalho MHB, Martinelli S, Zugaib M. 2007. Predicting preterm delivery in asymptomatic patients with prior preterm delivery by measurement of cervical length and phosphorylated insulinlike growth factor-binding protein-1. Ultrasound in Obstetrics and Gynecology 29:562-567. (Pubitemid 46826559)
2. Iams JD, Casal D, McGregor JA, Goodwin MT, Kreaden US, Lowensohn R et al. 1995. Fetal fi bronectin improves the accuracy of diagnosis of preterm labor. American Journal of Obstetrics and Gynecology 173:141-145.
3. Maria Paternoster D, Muresan D, Vitulo A, Serena A, Battagliarin G, Dell'Avanzo M, et al. 2007. Cervical phIGFBP-1 in the evaluation of the risk of preterm delivery. Acta Obstetricia et Gynecologica Scandinavica 86:151-155.
4. Rahkonen L, Rutanen E, Nuutila M, Sainio S, Saisto T, Paavonen J. 2010. Elevated levels of decidual insulin-like growth factor binding protein-1 in cervical fl uid in early and mid-pregnancy are associated with an increased risk of spontaneous preterm delivery. British Journal of Obstetrics and Gynaecology 117:701-710.
5. Rutanen EM. 2000. Insulin-like growth factors in obstetrics. Current Opinion in Obstetrics and Gynecology 12:163-168.
6. Shennan A, Crawshaw S, Briley A, Hawken J, Seed P, Jones G, et al. 2006. General obstetrics: a randomized controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fi bronectin: The PREMET Study. British Journal of Obstetrics and Gynaecology 113:65-74.
7. Slattery M, Morrison J. 2002. Preterm delivery. Lancet 360:1489-1497. (Pubitemid 35356329)
8. Ting H, Chin P, Yeo GSH, Kwek K. 2007. Comparison of bedside test kits for prediction of preterm delivery: phosphorylated insulin-like growth factor binding protein-1 (pIGFBP-1) test and fetal fi bronectin test. Annals of the Academy of Medicine, Singapore 36:399-402. (Pubitemid 47234388)